Xianghua Luo

Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival

J. Wagner, D. Weisdorf, M. Verneris, 2009, Bone Marrow Transplantation.

Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients

J. Wagner, D. Weisdorf, M. Verneris, 2009, Bone Marrow Transplantation.